Home › Coronary Artery Disease › NCT03504956
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
RecruitingHealthy volunteers welcome
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion: * Healthy Volunteers: male or female ≥ 18 years of age with a BMI\<30, with no history of cardiovascular disease * Patients: Medically stable, male or female ≥ 18 years of age who is have not suspected of having or has been diagnosed with coronary artery disease and undergone stenting or bypass surgery Exclusion: * Contraindications to MR imaging including mechanically, magnetically, or electrically activated implants, ferromagnetic implants and ferromagnetic foreign bodies, pregnancy. * Inability to tolerate MR imaging secondary to an inability to hold breath for a short time or have claustrophobia. * Non-compliant with visit instructions, including following procedure instructions * Severe allergy to animal dander or animal-instigated asthma * Specific to gadolinium-based contrast agents: Renal function test does not meet CSMC standard of care MRI contrast protocol requirements (GFR \<45ml/min) or previous allergic reaction to gadolinium-based contrast agents.\* * Volunteers who have had four or more prior previous gadolinium contrast scan
About the study
This study proposes to develop an MRI technique named Coronary Atherosclerosis T1-weighed Characterization (CATCH) that will improve the quality and reliability of coronary atherosclerosis evaluation, as well as simplify the scanning process and significantly shorten imaging time compared with conventional imaging methods.
What is being tested
- Cardiac MRI (device)
- Contrast (drug)
- Beta blocker (drug)
Sponsor: Cedars-Sinai Medical Center · Participants: 150 · Started: Jul 30, 2018
Contact the study team
- Rosalia (Sally) A De Leon · Phone: 310 423-7758
- Debiao Li, PhD · Phone: 310 423-7743
Official record on ClinicalTrials.gov — NCT03504956
Locations in the U.S.
| California | Cedars-Sinai Medical Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.